Export 875 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is G  [Clear All Filters]
2013
Leão, P. N., Costa, M., Ramos, V., Pereira, A. R., et al. (2013). Antitumor Activity of Hierridin B, a Cyanobacterial Secondary Metabolite Found in both Filamentous and Unicellular Marine Strains. PLoS ONE, 8(7).
Eamvijarn, A., Gomes, N. M., Dethoup, T., Buaruang, J., et al. (2013). Bioactive meroditerpenes and indole alkaloids from the soil fungus Neosartorya fischeri (KUFC 6344), and the marine-derived fungi Neosartorya laciniosa (KUFC 7896) and Neosartorya tsunodae (KUFC 9213). Tetrahedron, 69(40), 8583 - 8591.
Leal, S. S., Cardoso, I., Valentine, J. S., & Gomes, C. M. (2013). Calcium ions promote superoxide dismutase 1 (SOD1) aggregation into non-fibrillar amyloid: A link to toxic effects of calcium overload in amyotrophic lateral sclerosis (ALS)?. Journal of Biological Chemistry, 288(35), 25219 - 25228.
Ramos, E. M., Latourelle, J. C., Gillis, T., Mysore, J. S., et al. (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173 - 179.
Ramos, E. M., Latourelle, J. C., Gillis, T., Mysore, J. S., et al. (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173 - 179.
Ramos, E. M., Latourelle, J. C., Gillis, T., Mysore, J. S., et al. (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173 - 179.
Ramos, E. M., Latourelle, J. C., Gillis, T., Mysore, J. S., et al. (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173 - 179.
Francisco, T., Rodrigues, T. A., Freitas, M. O., Grou, C. P., et al. (2013). A cargo-centered perspective on the PEX5 receptor-mediated peroxisomal protein import pathway. Journal of Biological Chemistry, 288(40), 29151 - 29159.
Cruz-Mariño, T., Velázquez-Pérez, L., González-Zaldivar, Y., Aguilera-Rodríguez, R., et al. (2013). The Cuban program for predictive testing of SCA2: 11years and 768 individuals to learn from. Clinical Genetics, 83(6), 518 - 524.
Conde, C., Osswald, M., Barbosa, J., Moutinho-Santos, T., et al. (2013). Drosophila Polo regulates the spindle assembly checkpoint through Mps1-dependent BubR1 phosphorylation. EMBO Journal, 32(12), 1761 - 1777.
Braunlin, E., Rosenfeld, H., Kampmann, C., Johnson, J., et al. (2013). Enzyme replacement therapy for mucopolysaccharidosis VI: Long-term cardiac effects of galsulfase (Naglazyme®) therapy. Journal of Inherited Metabolic Disease, 36(2), 385 - 394.
Braunlin, E., Rosenfeld, H., Kampmann, C., Johnson, J., et al. (2013). Enzyme replacement therapy for mucopolysaccharidosis VI: Long-term cardiac effects of galsulfase (Naglazyme®) therapy. Journal of Inherited Metabolic Disease, 36(2), 385 - 394.
Braunlin, E., Rosenfeld, H., Kampmann, C., Johnson, J., et al. (2013). Enzyme replacement therapy for mucopolysaccharidosis VI: Long-term cardiac effects of galsulfase (Naglazyme®) therapy. Journal of Inherited Metabolic Disease, 36(2), 385 - 394.
Earnshaw, W. C., Allshire, R. C., Black, B. E., Bloom, K., et al. (2013). Esperanto for histones: CENP-A, not CenH3, is the centromeric histone H3 variant. Chromosome Research, 21(2), 101 - 106.
Earnshaw, W. C., Allshire, R. C., Black, B. E., Bloom, K., et al. (2013). Esperanto for histones: CENP-A, not CenH3, is the centromeric histone H3 variant. Chromosome Research, 21(2), 101 - 106.
Earnshaw, W. C., Allshire, R. C., Black, B. E., Bloom, K., et al. (2013). Esperanto for histones: CENP-A, not CenH3, is the centromeric histone H3 variant. Chromosome Research, 21(2), 101 - 106.
Earnshaw, W. C., Allshire, R. C., Black, B. E., Bloom, K., et al. (2013). Esperanto for histones: CENP-A, not CenH3, is the centromeric histone H3 variant. Chromosome Research, 21(2), 101 - 106.
Magro, F., Langner, C., Driessen, A., Ensari, A., et al. (2013). European consensus on the histopathology of inflammatory bowel disease. Journal of Crohn's and Colitis, 7(10), 827 - 851.
Guedes, A. C., Gião, M. S., Seabra, R., Ferreira, A. C. S., et al. (2013). Evaluation of the antioxidant activity of cell extracts from microalgae. Marine Drugs, 11(4), 1256 - 1270.
Guedes, A. C., Gião, M. S., Seabra, R., Ferreira, A. C. S., et al. (2013). Evaluation of the antioxidant activity of cell extracts from microalgae. Marine Drugs, 11(4), 1256 - 1270.
Misumi, Y., Ando, Y., Gonçalves, N. P., & Saraiva, M. J. (2013). Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis. Laboratory Investigation, 93(8), 911 - 920.
Silva, M. S., Ferreira, A. E. N., Gomes, R., Tomás, A. M., et al. (2013). Glyoxalase Enzymes in Trypanosomatids. In Trypanosomatid Diseases: Molecular Routes to Drug Discovery (pp. 153 - 166).
Durão, J., & Gales, L. (2013). Guest diffusion in dipeptide crystals. CrystEngComm, 15(8), 1532 - 1535.
Silva-Gomes, S., Appelberg, R., Larsen, R., Soares, M. P., & Gomes, M. S. (2013). Heme catabolism by heme oxygenase-1 confers host resistance to Mycobacterium infection. Infection and Immunity, 81(7), 2536 - 2545.
Petrakis, I., Mavroeidi, V., Stylianou, K., Andronikidi, E., et al. (2013). Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis. Amyloid, 20(3), 164 - 172.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | WHISTLEBLOWER CHANNEL | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 226 074 900 | email: info@i3s.up.pt | © copyright 2010 ibmc